Animal health and welfare as a public good: what do the public think?

This paper presents a novel perspective on an evolving policy area. The UK's withdrawal from the EU has led to the creation of a new Agriculture Act and proposals for significant changes to the way farming subsidies are structured in England. Underpinned by a 'public money for public goods' approach, where public goods are those outputs from the farm system which are not rewarded by markets, yet which provide benefits to many members of society.

Making a mark on the farm: the marks and traces of farm animals and infectious diseases in northern England.

Farmed animals are expected to move through farmed spaces in certain ways to maximise their productivity. These spaces are also designed to limit the movement of disease-causing organisms. However, both types of lifeforms do not always move in expected ways.

Potential anatomical triggers for plan adaptation of cervical cancer external beam radiotherapy.

This study aimed to identify potential anatomical variation triggers using magnetic resonance imaging for plan adaption of cervical cancer patients to ensure dose requirements were met over an external beam radiotherapy course. Magnetic resonance images (MRIs) acquired before and during treatment were rigidly registered to a pre-treatment computerised tomography (CT) image for 11 retrospective cervix cancer datasets. Target volumes (TVs) and organs at risk (OARs) were delineated on both MRIs and propagated onto the CT.

Cardiac Substructure Dose and Survival in Stereotactic Radiotherapy for Lung Cancer: Results of the Multi-Centre SSBROC Trial.

Background And Purpose: Stereotactic ablative body radiotherapy (SABR) is increasingly used for early-stage lung cancer, however the impact of dose to the heart and cardiac substructures remains largely unknown. The study investigated doses received by cardiac substructures in SABR patients and impact on survival.

Materials And Methods: SSBROC is an Australian multi-centre phase II prospective study of SABR for stage I non-small cell lung cancer.

Radiotherapy protocol compliance in routine clinical practice for patients with stages I-III non-small-cell lung cancer.

Introduction: Despite the availability of radiotherapy treatment protocols for lung cancer, considerable treatment variation occurs in clinical practice. This study assessed compliance with a radiotherapy protocol for the treatment of patients with stages I-III non-small-cell lung cancer (NSCLC) in routine clinical practice and to identify factors that were associated with compliance.

Methods: The Cancer Institute New South Wales eviQ treatment protocol for external beam radiotherapy of stages I-III NSCLC was taken as the reference to measure compliance.